- Home
- RGC vs RVTY Comparison
RGC vs RVTY Comparison
Compare RGC & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGC | RVTY |
|---|---|---|
| Founded | 2014 | 1937 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 11.8B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RGC | RVTY |
|---|---|---|
| Price | $25.30 | $98.55 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $113.00 |
| AVG Volume (30 Days) | 106.1K | ★ 1.2M |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.07 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | N/A | $6.34 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | ★ N/A | $47.49 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.99 | $81.36 |
| 52 Week High | $950.00 | $120.39 |
Technical Indicators
Market Signals| Indicator | RGC | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 43.09 | 47.29 |
| Support Level | $11.83 | $88.56 |
| Resistance Level | $26.42 | $99.54 |
| Average True Range (ATR) | 2.42 | 3.07 |
| MACD | -0.55 | 0.17 |
| Stochastic Oscillator | 15.00 | 81.39 |
Price Performance
Historical ComparisonAbout RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.